免费预览已结束,剩余1页可下载查看
下载本文档
版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领
文档简介
Guidance MEDDEVsThe guidelines aim at promoting a common approach by manufacturers and Notified Bodies involved in the conformity assessment procedures according to the relevant annexes of the Directives, and by the Competent Authorities charged with safeguarding Public Health.They have been carefully drafted through a process of consultation with various interested parties during which intermediate drafts were circulated and comments were taken up in the documents. Therefore, they reflect positions taken in particular by representatives ofCompetent Authoritiesand Commission Services, Notified Bodies, industry andother interested partiesin the medical devices sector.The guidelines are not legally binding. It is recognised that under given circumstances, for example, as a result of scientific developments, an alternative approach may be possible or appropriate to comply with the legal requirements.Due to the participation of the aforementioned interested parties and of experts from Competent Authorities, it is anticipated that the guidelines will be followed within the Member States and, therefore, ensure uniform application of relevant Directive provisions. Guidelines are subject of a regular updating process.Disclaimer: Please note that the amendments introduced by Directive 2007/47/EC or previous amending directives have not yet been incorporated in all MEDDEVs. The necessary revision is under way.TITLE2.1Scope, field of application, definitionMEDDEV 2.1/1(19 KB)Definitions of medical devices, accessory and manufacturerApril 1994MEDDEV 2.1/2 rev.2(14 KB)Field of application of directive active implantable medical devicesApril 1994MEDDEV 2.1/2.1(12 KB)Field of application of directive active implantable medical devicesFebruary 1998MEDDEV 2.1/3 rev.3(182 KB)Borderline products, drug-delivery products and medical devices incorporating,as integral part, an ancillary medicinal substance or an ancillary human blood derivativeDecember 2009MEDDEV 2.1/4(21 KB)Interface with other directives - Medical devices/directive89/336/EEC relating to electromagnetic compatibility and directive 89/686/EEC relating to personal protective equipmentMarch 1994For the relation between the MDD and directive 89/686/EEC concerning personal protectiveequipment, please see the Commission servicesinterpretative document of 21 August 2009(32 KB)MEDDEV 2.1/5(10 KB)Medical devices with a measuring functionJune 1998MEDDEV 2.1/6(323 KB)Qualification and Classification of stand alone softwareJanuary 20122.2Essential requirementsMEDDEV 2.2/1 rev.1(16 KB)EMC requirementsFebruary 1998MEDDEV 2.2/3 rev.3(17 KB)Use by - dateJune 1998MEDDEV 2.2/4(39 KB)Conformity assessment of In Vitro Fertilisation (IVF) and Assisted Reproduction Technologies (ART) productsJanuary 20122.4Classification of MDMEDDEV 2.4/1 rev.9(654 KB)Classification of medical devicesJune 20102.5Conformity assessment procedureGeneral rulesQuality assurance.Regulatory auditing of quality systems of medical device manufacturers(See document in the GHTF-Global Harmonization Task Force)MEDDEV 2.5/3 rev.2(9 KB)Subcontracting quality systems relatedJune 1998MEDDEV 2.5/5 rev.3(7 KB)Translation procedureFebruary 1998MEDDEV 2.5/6 rev.1(10 KB)Homogenous batches (verification of manufacturers products)February 1998Conformity assessment for particular groups of productsMEDDEV 2.5/7 rev.1(93 KB)Conformity assessment of breast implantsJuly 1998Evaluation of medical devices incorporating products of animal origin.(SeeMEDDEV 2.11/1 rev.2(82 KB)MEDDEV 2.5/9 rev.1(97 KB)Evaluation of medical devices incorporating products containing natural rubber latexFebruary 2004MEDDEV 2.5/10(78 KB)Guideline for Authorised RepresentativesJanuary 20122.7Clinical investigation, clinical evaluationMEDDEV 2.7/1 rev.3(378 KB)Clinical evaluation: Guide for manufacturers and notified bodiesDecember 2009Appendix 1: Clinical evaluation on coronary stents(101 KB)December 2008MEDDEV 2.7/2(37 KB)Guide for Competent Authorities in making an assessment of clinical investigation notificationDecember 2008MEDDEV 2.7/3(166 KB)Clinical investigations: serious adverse event reporting-SAE reporting form(87 KB)December 2010MEDDEV 2.7/4(180 KB)Guidelines on Clinical investigations: a guide for manufacturers and notified bodiesDecember 20102.10Notified bodiesMEDDEV 2.10/2 rev.1(105 KB)Designation and monitoring of Notified Bodies within the framework of EC Directives on Medical devicesAnnex 1(120 KB),Annex 2(14 KB),Annex 3(17 KB),Annex 4(26 KB)April 20012.12Market surveillanceMEDDEV 2.12/1 rev.8(745 KB)Medical Devices Vigilance SystemJanuary 2013Manufacturer Incident Report(971 KB)How to use the MIR(13 KB)Field Safety Corrective Action(2 MB)Trend Report(151 KB)Periodic Summary Report(192 KB)MIR and FSCA xml files(2 MB)List of contact pointsMEDDEV 2.12/2rev.2(221 KB)Post Market Clinical Follow-up studiesJanuary 20122.13Transitional periodMEDDEV 2.13 rev.1(13 KB)Commission communication on the application of transitional provision of Directive 93/42/EEC relating to medical devices (OJ 98/C 242/05)August 1998As regards the transitional regime of Directive 2007/47/EC see theInterpretative Document of the Commissions services of 5 June 2009(36 KB)2.14IVDMEDDEV 2.14/1 rev.2(75 KB)Borderline and Classification issues. A guide for manufacturers and notified bodiesJanuary 2012MEDDEV 2.14/2 rev.1(64 KB)Research Use Only productsFebruary 2004MEDDEV 2.14/3 rev.1(80 KB)Supply of Instructions For Use (IFU) and other information for In-vitro Diagnostic (IVD)Medical DevicesJanuary 2007Form for the registration of manufacturers and devices In Vitro Diagnostic Medical DeviceDirective, Article 10(213 KB)Ja
温馨提示
- 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
- 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
- 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
- 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
- 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
- 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
- 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
最新文档
- 参会代表回执单
- 2024年电脑租赁协议经典版(2篇)
- 2024年工程建筑内部分包合同(二篇)
- 2024年二手房购房定金合同标准版本(二篇)
- 2024年临时用工协议范本(2篇)
- 2024年总代理合同常规版(三篇)
- 2024年服装代理合同参考范本(5篇)
- 2024年知识产权共享协议标准版本(3篇)
- 2024年北京市材料买卖合同(二篇)
- 2024年详细版车辆合伙经营合同范本(二篇)
- 运动鞋行业宏观环境分析
- 改革开放与新时代智慧树知到期末考试答案2024年
- 《测试反应快慢》课件
- 广东省莞市东华中学2024年中考语文全真模拟试题含解析
- 提升科普服务能力
- 法治税务示范基地创建方案
- 委托书:代我支付土地出让金
- 2023年天津市中考数学试卷(含答案)
- 住宅小区清洁服务 投标方案(技术方案)
- 特警群防群治工作总结
- 基于plc的四路抢答器
评论
0/150
提交评论